Body weight slashed by 20% in new anti-obesity drug trial

Preliminary data from a large Phase 3 clinical trial is offering promising signs for a new anti-obesity drug. Called tirzepatide, the drug helped overweight and obese participants lose up to 22.5 percent of their total body weight over the 72-week trial.

Read more

Show More

Related Articles

Back to top button